OpiCalc Logo

OpiCalc

989 Clinical Tools

Logo
OpiCalc
APGAR ScoreAssisted Delivery (FIGO)BPP (Manning Score)Bishop ScoreCARPREG II Cardiac RiskCervical Cancer StagingContraceptive Pearl IndexDoppler Matrix (UA/MCA)EFW (Hadlock)Endometrial StagingEndometrial ThicknessFGR Criteria (Consensus)FSFI (Sexual Function)Ferriman-Gallwey ScoreFetal Anemia (MCA PSV)GDM Diagnostic CriteriaGPA History IndicatorGail Model Breast RiskGestational Dating (LMP)HIV PMTCT ProtocolIOTA Simple RulesIVF Due Date & AMHIron Deficit (Ganzoni)Labour Progress (WHO)Maternal Sepsis (qSOFA)O-RADS ClassificationOvarian Cancer StagingPAS Hemorrhage RiskPPH Protocol (FIGO)Preeclampsia (ACOG)Rho(D) Dose (K-B)Rotterdam PCOS CriteriaSyphilis ManagementTORCH FrameworkVBAC Success ProbabilityVulvar Cancer StagingWeight Gain (IOM)mWHO Cardiac Risk
OpiCalc Logo

OpiCalc

Open-access clinical infrastructure. Built to the standard every clinician deserves — fast, private, and free.

Zero data stored
Always free
Our mission & transparency

Get in Touch

Tool request, clinical feedback, or partnership inquiry — we read everything.

WhatsApp feedback
Email us
Partnership inquiry

© 2026 OpiCalc • Calculated Care

ProtocolsAboutPrivacyTerms

mWHO Cardiac Risk

Guidelines & Evidence

Clinical Details

Section 1

When to Use

Primary Clinical Uses

Pre-conception counseling for women with structural or functional heart disease.
Directing the frequency of multidisciplinary maternal-fetal and cardiology surveillance during pregnancy.
Determining absolute contraindications to pregnancy.

Hemodynamic Crisis

Pregnancy induces a 50% increase in blood volume and cardiac output. The mWHO scale predicts which diseased hearts will catastrophically decompensate under this unique, 9-month physiologic stress test.
Section 2

Formula & Logic

Class I & II (Low to Moderate Risk)

Class IUncomplicated, small/mild: pulmonary stenosis, PDA, mitral prolapse, repaired simple lesions. Risk of mortality essentially nil.
Class IIUnoperated ASD/VSD, repaired Tetralogy of Fallot, most arrhythmias. Mortality < 1%.
Class II-IIIMild LV impairment, Hypertrophic cardiomyopathy, Marfan syndrome without aortic dilation.

Class III & IV (High to Extreme Risk)

Class IIIMechanical valves, Systemic Right Ventricle, Fontan circulation, Unrepaired cyanotic heart disease. High risk of severe morbidity.
Class IVPulmonary Arterial Hypertension (PAH), Severe symptomatic Aortic/Mitral stenosis, Marfan with aorta >45mm, LV Ejection Fraction <30%. Pregnancy contraindicated.
Section 3

Pearls/Pitfalls

Notorious Pitfalls

Pulmonary Arterial Hypertension (PAH) carries a maternal mortality rate of 20-50%. If a Class IV patient presents pregnant, termination is strongly medically advised.
Mechanical valves (Class III) are incredibly difficult to manage. Warfarin is highly teratogenic, but switching to heparin exponentially increases the risk of maternal mechanical valve thrombosis and death. It strictly requires a highly specialized cardio-obstetrics team.
Peri-partum cardiomyopathy is a uniquely unpredictable, often catastrophic heart failure that develops in the last month of pregnancy or first few months postpartum, regardless of prior baseline.
Section 4

Next Steps

Management Triggers

01
Class I: Routine prenatal care with 1-2 cardiology visits.
02
Class II: Delivery at local hospital is generally safe; cardiology review every trimester.
03
Class III: Requires delivery at a highly-resourced tertiary care center with cardiothoracic surgery on standby. Bi-monthly cardiology/MFM visits.
04
Class IV: If patient refuses termination, requires extreme surveillance. Planned early delivery (often via planned C-section in a cardiac OR) with intensive care team.
Section 5

Evidence Appraisal

European Society of Cardiology

2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy.

Regitz-Zagrosek V et al. • Eur Heart J.. 2018;The definitive societal guideline that operationalized the Modified WHO classification as the gold standard predictive metric over legacy systems like the CARPREG score.

Section 6

Literature

Evolution of Maternal Cardiology

Historically, women with complex congenital heart disease did not survive into childbearing age. Surgical advancements created an entirely new demographic of pregnant women with repaired (but not normal) hearts, necessitating the creation of the mWHO index.

Last Comprehensive Review: 2026

Related Obstetrics Tools

APGAR Score
Assisted Delivery
Bishop Score
BPP
CARPREG II Cardiac Risk
Cervical Cancer Staging
Contraceptive Pearl Index
Doppler Matrix
EFW
Endometrial Staging
Have feedback about this calculator?Let us know.